Gnmt−/− mice gradually progresses to steatohepatitis, cirrhosis and HCC; therefore, these mice serve as a useful tool to uncover underlying molecular mechanisms and to develop therapeutic agents against the pathogenesis of HCC. The gene discussed is GNMT; the disease is hepatocellular carcinoma.